These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 12442660)

  • 61. Oscillations in the basal ganglia under normal conditions and in movement disorders.
    Gatev P; Darbin O; Wichmann T
    Mov Disord; 2006 Oct; 21(10):1566-77. PubMed ID: 16830313
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A computational model of Parkinsonian handwriting that highlights the role of the indirect pathway in the basal ganglia.
    Gangadhar G; Joseph D; Srinivasan AV; Subramanian D; Shivakeshavan RG; Shobana N; Chakravarthy VS
    Hum Mov Sci; 2009 Oct; 28(5):602-18. PubMed ID: 19720411
    [TBL] [Abstract][Full Text] [Related]  

  • 64. From basal ganglia to motoneurons. Probable involvement of pathways relaying in the medulla.
    Delwaide PJ; Pepin JL; Maertens de Noordhout A
    Adv Neurol; 1996; 69():111-6. PubMed ID: 8615117
    [No Abstract]   [Full Text] [Related]  

  • 65. [Basal ganglia disease. Functional neuroanatomy and therapeutic perspectives].
    Ostergaard K; Sunde NA; Dupont E
    Ugeskr Laeger; 2000 Oct; 162(41):5480-3. PubMed ID: 11068522
    [No Abstract]   [Full Text] [Related]  

  • 66. Selective loss of pyramidal neurons in the pre-supplementary motor cortex in Parkinson's disease.
    MacDonald V; Halliday GM
    Mov Disord; 2002 Nov; 17(6):1166-73. PubMed ID: 12465053
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Extrastriatal dopamine and Parkinson's disease.
    Parent A; Cossette M
    Adv Neurol; 2001; 86():45-54. PubMed ID: 11554008
    [No Abstract]   [Full Text] [Related]  

  • 68. Understanding Parkinsonian handwriting through a computational model of basal ganglia.
    Gangadhar G; Joseph D; Chakravarthy VS
    Neural Comput; 2008 Oct; 20(10):2491-525. PubMed ID: 18386983
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Surgery for Parkinson's disease, the five W's: why, who, what, where, and when.
    Lozano AM
    Adv Neurol; 2003; 91():303-7. PubMed ID: 12442688
    [No Abstract]   [Full Text] [Related]  

  • 70. Commentary: olfactory dysfunction in Parkinson's disease.
    Li J; Cui Y; Yuan TF; Arias-Carrion O
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1079-80. PubMed ID: 24392859
    [No Abstract]   [Full Text] [Related]  

  • 71. Basic research in substantia nigra and ventral tegmental area: clinical implications.
    Stratta F; Bonci A; Calabresi P; Stefani A; Pisani A; Bernardi G; Mercuri NB
    J Neural Transm Suppl; 1995; 45():47-55. PubMed ID: 8748608
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dysfunction of the basal ganglia, but not the cerebellum, impairs kinaesthesia.
    Maschke M; Gomez CM; Tuite PJ; Konczak J
    Brain; 2003 Oct; 126(Pt 10):2312-22. PubMed ID: 12821507
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonmotor functions of the basal ganglia.
    Bodis-Wollner I; Yahr MD; Mylin LH
    Adv Neurol; 1984; 40():289-98. PubMed ID: 6695605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Contributions of functional imaging to understanding parkinsonian symptoms.
    Grafton ST
    Curr Opin Neurobiol; 2004 Dec; 14(6):715-9. PubMed ID: 15582373
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The globus pallidus pars externa and Parkinson's disease. Ready for prime time?
    Obeso JA; Rodriguez-Oroz MC; Javier Blesa F; Guridi J
    Exp Neurol; 2006 Nov; 202(1):1-7. PubMed ID: 16920102
    [No Abstract]   [Full Text] [Related]  

  • 76. A pathophysiological model of freezing of gait in Parkinson's disease.
    Lewis SJ; Barker RA
    Parkinsonism Relat Disord; 2009 Jun; 15(5):333-8. PubMed ID: 18930430
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry.
    Kravitz AV; Freeze BS; Parker PR; Kay K; Thwin MT; Deisseroth K; Kreitzer AC
    Nature; 2010 Jul; 466(7306):622-6. PubMed ID: 20613723
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Striatal and extrastriatal dopamine in the basal ganglia: an overview of its anatomical organization in normal and Parkinsonian brains.
    Smith Y; Villalba R
    Mov Disord; 2008; 23 Suppl 3():S534-47. PubMed ID: 18781680
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Influence of age and gender on cytokine expression in a murine model of Parkinson's disease.
    Ciesielska A; Joniec I; Kurkowska-Jastrzebska I; Przybyłkowski A; Gromadzka G; Członkowska A; Członkowski A
    Neuroimmunomodulation; 2007; 14(5):255-65. PubMed ID: 18196934
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse.
    Chassain C; Bielicki G; Durand E; Lolignier S; Essafi F; Traoré A; Durif F
    J Neurochem; 2008 May; 105(3):874-82. PubMed ID: 18088356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.